End Cash: The amount of cash held by the company for the given period.
Aldeyra Therapeutics, Inc. (ALDX) had End Cash of $59.34M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.69M |
|
-- |
|
-- |
|
$8.00M |
|
$-8.00M |
|
$0.31M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
$-8.00M |
|
$-8.20M |
|
60.13M |
|
60.13M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$77.46M |
|
-- |
|
$0.34M |
|
$77.80M |
|
$28.48M |
|
-- |
|
$0.07M |
|
$28.56M |
|
$49.24M |
|
$49.24M |
|
$49.24M |
|
60.16M |
|
| Cash Flow Statement Financials | |
$-28.05M |
|
$31.74M |
|
$1.12M |
|
$54.53M |
|
|
End Cash |
$59.34M |
$4.81M |
|
$5.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.72 |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.61% |
|
-15.61% |
|
-9.88% |
|
-15.61% |
|
$0.82 |
|
$-0.47 |
|
$-0.47 |
|